Tandem Diabetes Care (NASDAQ:TNDM) today announced FDA clearance of bolus insulin dosing on the t:slim X2 insulin pump using the t:connect mobile app. Company officials boasted that the t:connect mobile app is now the first smartphone app FDA-cleared for insulin delivery on both the iOS and Android operating systems. Tandem Diabetes Care plans to roll […]
Califf’s returning as FDA commissioner
The U.S. Senate confirmed Dr. Robert Califf as FDA commissioner in a 50-46 vote today. The vote capped a months-long campaign to secure Califf’s confirmation after President Joe Biden nominated him to return to the post he held near the end of the Obama administration. The Senate voted 49-45 yesterday on a cloture vote to […]
Steris up on Street-beating Q3 results
Steris (NYSE:STE) reported fiscal third-quarter results that beat the consensus forecast on Wall Street, upping its fiscal 2022 forecast. The infection prevention technology company — headquartered in Dublin, Ireland and run operationally out of Mentor, Ohio — earned $143.6 million, or $1.42 per share, off $1.2 billion in revenue for the quarter ended Dec. 31, […]
Medline Industries revenue up nearly 15% in 2021
Medline Industries’ sales grew nearly 15% to $20.1 billion last year as the medtech manufacturer and distributor added more than 230 additional healthcare providers to its prime vendor partnerships. The new relationships, announced today, were worth nearly $2 billion in annual, incremental sales of medical supplies and services spanning the care continuum. The new health […]
Align Technology settles patent infringement, antitrust suits with 3Shape
Align Technology (Nasdaq: ALGN) has settled its five-year legal dispute with Denmark-based dental scanner and software maker 3Shape. The settlement, announced yesterday, covers 3Shape’s patent infringement claims pending in federal courts in Delaware and eastern Texas. 3Shape also had an antitrust claim pending against Align in Delaware District Court, and both companies had petitions to […]
CooperCompanies to buy Cook Medical’s reproductive health business for $875M
Cook Medical has signed a letter of intent to sell its Reproductive Health business to CooperCompanies, the two companies announced today. CooperCompanies (NYSE:COO) plans to pay privately-held Cook Medical $875 million: $675 million at closing, then the remaining $200 million paid in four $50 million annual installments. The proposed deal — which could close in […]
ZB’s upcoming spinoff ZimVie expecting flat revenue in 2022
ZimVie — the upcoming spinoff of Zimmer Biomet’s spine and dental business — is forecasting that annual revenue will stay flat at $1 billion in 2022. The news was part of ZimVie management’s announcement of an Investor Day today. They said plans for the spinoff remain on track, with ZimVie shares commencing trading on March […]
HeartFlow SPAC deal is called off
HeartFlow and a special purpose acquisition company called Longview Acquisition Corp. have called off merger plans that would have taken the cardiac test company public. HeartFlow, in a news release out this evening, described the move as a mutual decision — a “result of current unfavorable market conditions.” Stock markets in the U.S. have been […]
Johns Hopkins-led team’s robot performs laparoscopic surgery without human help
A Johns Hopkins University research team has created a robot that can perform laparoscopic surgery on a pig’s soft tissue without a human being’s aid. The researchers described their latest advance with their Smart Tissue Autonomous Robot (STAR) in the January 26 issue of Science Robotics. “Our findings show that we can automate one of the most […]
Cardinal Health’s Medical segment saw Q2 profits drop 79%
Cardinal Health (NYSE:CAH) today reported mixed second quarter results and cut its EPS guidance as the company’s Medical segment continues to wrestle with inflation and supply chain problems. The Dublin, Ohio–based pharma and medtech giant reported profits of $49 million, or 17¢ per share, on sales of $45.5 million for the three months ended Dec. […]
Corvia Medical’s atrial shunt trial fails primary endpoint
Corvia Medical’s atrial shunt device did not reduce heart failure rates or improve health status in a 626-patient study published on The Lancet’s website. The REDUCE LAP-HF II results appear to be bad news for Tewksbury, Massachusetts-based Corvia — as well as Edwards Lifesciences, which agreed in 2019 to pay $35 million for the rights […]